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Aging is associated to a progressive establishing of a chronic inflammatory state linked to a continuous long exposure to antigens.
Since IL-15 stimulates the proliferation of memory T cells and the immunosenescence is characterized by accumulation of memory
T cells and exhaustion of naive T cells, we analyzed IL-15 levels in sera from 30 ultralongeval subjects with respect to those from
young and old adults. IL-15 levels were assayed by immunoenzymatic methods. Ultralongeval subjects displayed significantly higher
IL-15 levels with respect to both young and old controls. No statistical difference was found between old and young controls. These
findings may explain, at least in part, the characteristic increase of memory cells in immunosenescence and the capacity of the
immune system of centenarians to defend itself from infections through immune-inflammatory responses.
INTRODUCTION
Accumulating evidences strongly suggest that aging is
associated to a progressive establishing of a chronic in-
flammatory state characterized by the release of several
proinflammatory cytokines, linked to a continuous long
exposure to antigens, which appears to be under genetic
control [1].
The beneficial effects of the immune system, devoted
to the neutralization of harmful agents early in life, be-
come detrimental and could explain the pathogenesis of
the age-related diseases, such as atherosclerosis, diabetes,
neurodegeneration [1].
It has been demonstrated that all the components of
immune system show age-related dysregulation, and nu-
merous studies have been performed in order to investi-
gate the cytokine network in elderly people with conflict-
ing results.
Interleukin (IL)-15, a monocyte- and epithelial-cell-
derived cytokine, produced in response to environmental
stimuli and infectious agents, shares a variety of biological
functions including stimulation and maintenance of cel-
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lular immune response [2]. This cytokine, similar to IL-2
in receptor specificity and biological functions (the speci-
ficity for IL-15 is provided by unique private α-chain re-
ceptors), is important for the growth and differentiation
of B and T lymphocytes, NK cells, macrophages, and
monocytes. The heterotrimeric IL-15 receptor (IL-15R)
consists of IL-15Rα, which uniquely binds IL-15, as well as
IL-2Rβ and γc, which mediate signal transduction events
after IL-2 and IL-15 binding [2].
IL-15 is characterized by a pleiotropic activity that re-
sults in immunoregulatory cross-talk between natural and
specific immune cells [2].
Moreover, IL-15 induces the differentiation of func-
tional CD56+ NK cells from CD34 haematopoietic cells,
allowing innate immune defense against viruses, fungi,
bacteria, and protozoa [2].
In order to investigate whether this important cy-
tokine is influenced by aging, we analyzed IL-15 levels in
sera from ultralongeval subjects (> 95 years), elderly sub-
jects (60–89 years), and adults aged less than 60 years.
We investigated 30 ultralongeval subjects (26 female,
4 male; 12 aged 95–99 years, and 18 ultracentenarians).
All ultralongeval subjects were living at home inde-
pendently and able to carry out usual day activity on their
own or with little help. They were in good health, no
smokers, without past or present history of myocardial
infarction, acute cerebrovascular events, diabetes, cancer,
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Figure 1. Age-related changes in serum IL-15 levels. Box blot il-
lustrates median of IL-15 in groups of individuals with different
ages.
or nephropathy. 42 healthy sex-matched individuals were
also recruited as controls and divided into two groups:
group A (n = 21, age range 60–89 years) and group B
(n = 21, age range 30–59 years). All subjects gave a writ-
ten informed consent to participate in the study.
A 10-mL blood sample was collected from the antecu-
bital vein, allowed to clot at room temperature for 2 hours,
separate by centrifugation at 200-xg for 15 minutes in a
4235A centrifuge (ALC Int SrL, Milan, Italy), and stored
at-80◦C until use.
IL-15 levels were assayed by immunoenzymatic meth-
ods (Quantikine Human IL-15, ELISA-kits, R&D System,
SPACE Import-Export, Milan, Italy). The minimum de-
tectable concentration of IL-15 is 2 pg/mL.
Differences in IL-15 levels were assessed by the
Wilcoxon Signed Rank Test. Data are expressed as mean
± standard deviation (SD). A P value < .05 was consid-
ered significant.
All data were analyzed using the Stat View SE program
(Abacus, Berkeley, Calif, USA).
IL-15 serum levels were significantly higher in ultra-
longeval subjects with respect to both old and young con-
trols (3.05± 1.41 versus 1.94± 1.32 pg/mL, P = .011, and
versus 1.73 ± 0.50 pg/mL, P = .001, respectively) (Figure
1).
No statistical difference was found between old and
young controls.
First data of our study show that there are not statis-
tically significant differences between old and young con-
trols. These results are in agreement with those reported
by Tortorella et al, although in different experimental con-
ditions. In fact, after a 24-hour PHA stimulation, PBMC
from aged donors produced IL-15 at levels similar to those
found in the young [3].
But in this paper, Tortorella showed also that IL-15
modulation on PHA-induced IFN-gamma production by
PBMC determined a sixfold increase in cytokine values
in the young volunteers, but only a 1.7-fold increase in
the group of aged subjects. Furthermore, IL-15 added to
PBMC cultures enhanced the PHA-triggered T-cell prolif-
erative response only in young individuals, being ineffec-
tive in the old counterparts [3].
This impairment of IL-15 signaling in the elderly sub-
jects may be related to a reduction in IL-15 receptors or in
the activity of kinases involved in cytokine-triggered cell
signaling [3].
Centenarians can be considered as a useful model for
the study of the biological basis of healthy aging.
Aging is characterized by a chronic inflammatory sta-
tus also called “inflammaging,” in which the upregulation
of antistress responses is the consequence of the ability of
the body to adapt to and counteract the effects of stressors,
which causes the accumulation of molecular and cellular
scars [1]. In particular, centenarians display increased cir-
culating levels of inflammation markers, including IL-6,
ICAM-1, and IL-18 [4].
Moreover, continuous exposure to antigens causes a
lifelong antigenic stress responsible, together with the in-
volution of the thymus, for the accumulation of mem-
ory/effector T cells and the exhaustion of naive T cells
[1].
IL-15 stimulates the proliferation of human mem-
ory (CD45RO+) CD4, CD8, and naive (CD45RO) CD8+
human T cells in vitro, while having no effect on naive
CD4 T lymphocytes, consistent with IL-2/15Rβ expres-
sion [2].
Recently, Burkett et al showed that expression of the
high-affinity receptor for IL-15 (IL-15Rα on T cells is dis-
pensable for the generation or survival of memory CD8+
T cells, whereas IL-15Rα expression on other cells is criti-
cal for supporting memory CD8+ T cells [5]).
These findings demonstrate that IL-15Rα supports
memory CD8+ T cells entirely through non-cell-
autonomous mechanisms, probably related to the ability
of IL-15Rα to present IL-15 in trans to IL-15Rβ/γc low-
affinity receptors.
In the present study, we demonstrated, for the first
time, that ultralongeval subjects displayed significantly
higher circulating IL-15 compared to each of the two age-
control populations.
Then, our findings may explain, at least in part, the
increase of memory cells characteristic of elderly subjects
[1].
On the other hand, IL-15 induces the differentiation
of functional CD56+ NK cells from CD34 haematopoietic
cells and CD56+ NK cells have a key role in innate im-
mune defense against viruses, fungi, bacteria, and proto-
zoa [2].
So, this demonstration of the strong increase of IL-15
in ultralongeval subjects may contribute to a better under-
standing of themechanisms at the basis of the well-known
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capacity of the immune system of centenarians to de-
fend itself from infections through efficient immune-
inflammatory responses that may be crucial for longevity.
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